SEC Filing Summary: BioSig Technologies, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on August 21, 2014, covering events occurring on August 15, 2014. The filing details a private placement transaction and related corporate amendments.
Key Financial Metrics and Transaction Details
- Capital Raised: $563,000 in aggregate consideration from the Initial Private Placement.
- Securities Issued: 225,200 shares of Common Stock and five-year warrants to purchase 112,600 shares.
- Warrant Terms: Exercise price of $2.75 per share; exercisable immediately for cash or cashless after six months if no registration statement is effective.
- Dilution: The securities issued represented less than 5% of outstanding Common Stock.
- Future Capacity: The Purchase Agreement allows for up to $1,000,000 in total sales through multiple closings until August 30, 2014 (extendable to September 30, 2014).
- Liquidity and Debt: The filing text does not provide specific data on current cash flow, operating margins, or existing debt levels.
Material Changes and Agreements
The Company entered into a Securities Purchase Agreement and a Registration Rights Agreement with accredited investors. Key terms include:
- Registration Rights: The Company must file a registration statement for the resale of securities within 45 days of September 30, 2014.
- Liquidated Damages: If registration deadlines are missed, the Company owes 1.0% of the purchase price per month of delinquency, capped at 3% total. Unpaid damages accrue interest at 18% per annum.
- Corporate Amendment: The Company filed a Certificate of Amendment to its Charter to update the definition of "Purchase Agreement."
Outlook, Risks, and Contingencies
The primary contingency is the Company's ability to meet the strict registration deadlines to avoid liquidated damages. The transaction relies on exemptions under Section 4(2) and Regulation D of the Securities Act. The filing notes that the summaries of agreements are qualified by reference to the full exhibits.
Investor Verification Checklist
- Verify the total amount raised under the Purchase Agreement by the August 30, 2014 deadline.
- Confirm the filing date and effectiveness status of the required registration statement by mid-November 2014.
- Review the full text of the Securities Purchase Agreement and Registration Rights Agreement (Exhibits 10.1 and 10.3) for specific covenants.
- Assess the impact of the 18% interest penalty on unpaid liquidated damages if registration delays occur.